These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 8640855

  • 41. Electrocardiogram-electrogram desynchronization while using radiofrequency wandless telemetry during implantation of an implantable cardioverter defibrillator.
    Cano O, Osca J, Buendía F, Sancho-Tello MJ, Olagüe J, Salvador A.
    Europace; 2011 Feb; 13(2):291-2. PubMed ID: 20798116
    [No Abstract] [Full Text] [Related]

  • 42. The contradiction of appropriate shocks in primary prevention ICDs: increasing and decreasing the risk of death.
    Sweeney MO.
    Circulation; 2010 Dec 21; 122(25):2638-41. PubMed ID: 21135359
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Implantable cardioverter-defibrillator placement via a single persistent left superior vena cava in secondary prevention of sudden cardiac death in a patient with Turner syndrome.
    Steckiewicz R, Świętoń E, Stolarz P, Grabowski M.
    Kardiol Pol; 2015 Dec 21; 73(12):1334. PubMed ID: 26727672
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Cardiac arrhythmias (XII). The implantable automatic defibrillator as the treatment of malignant ventricular arrhythmias].
    Block M, Hammel D, Martínez Rubio A, Breithardt G.
    Rev Esp Cardiol; 1993 Dec 21; 46(12):821-36. PubMed ID: 8134696
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Is the wearable cardioverter-defibrillator the answer for early post-myocardial infarction patients at risk for sudden death?: mind the gap.
    Zei PC.
    J Am Coll Cardiol; 2013 Nov 19; 62(21):2008-2009. PubMed ID: 23916931
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Impact of implantable cardioverter-defibrillator therapy on a secondary prevention population.
    Rathod A, Badheka A, Deshmukh A.
    JAMA Intern Med; 2013 Nov 19; 173(22):2093-4. PubMed ID: 24322466
    [No Abstract] [Full Text] [Related]

  • 53. Impact of implantable cardioverter-defibrillator therapy on a secondary prevention population--reply.
    Borne RT, Varosy PD, Masoudi FA.
    JAMA Intern Med; 2013 Nov 19; 173(22):2094. PubMed ID: 24322468
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. ICD therapy: the be all and end all?
    Guha K.
    Eur J Intern Med; 2010 Apr 19; 21(2):e13; author reply e14. PubMed ID: 20206866
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Cardiomyoplasty combined with implantation of a cardioverter defibrillator.
    Chekanov VS, Deshpande S, Schmidt DH.
    J Thorac Cardiovasc Surg; 1997 Sep 19; 114(3):489-91. PubMed ID: 9305204
    [No Abstract] [Full Text] [Related]

  • 60. Use of the implantable cardioverter-defibrillator in patients with coronary artery spasm as the apparent cause of spontaneous life-threatening ventricular tachycardia or ventricular fibrillation: crossing the spasm sudden death chasm.
    Mitchell LB.
    J Am Coll Cardiol; 2012 Sep 04; 60(10):914-6. PubMed ID: 22840526
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.